Thrombogenic risk factors for cardiovascular disease in dialysis patients

被引：11

作者：

Culleton, BF ^{[1
]}

Wilson, PWF ^{[1
]}

机构：

[1] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA

来源：

SEMINARS IN DIALYSIS | 1999年 / 12卷 / 02期

关键词：

D O I：

10.1046/j.1525-139X.1999.00002.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：117 / 125

页数：9

共 142 条

[71] Lipoprotein(a) in renal disease [J].

Kronenberg, F ;

Utermann, G ;

Dieplinger, H .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (01) :1-25

[72]

KRONENBERG F, 1995, J AM SOC NEPHROL, V6, P110

[73]

Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963

[74]

LEE SW, 1998, J AM SOC NEPHROL, V9, P236

[75] Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? [J].

Levey, AS ;

Beto, JA ;

Coronado, BE ;

Eknoyan, G ;

Foley, RN ;

Kasiske, BL ;

Klag, MJ ;

Mailloux, LU ;

Manske, CL ;

Meyer, KB ;

Parfrey, PS ;

Pfeffer, MA ;

Wenger, NK ;

Wilson, PWF ;

Wright, JT .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :853-906

[76] LIPOPROTEINS INHIBIT THE SECRETION OF TISSUE-PLASMINOGEN ACTIVATOR FROM HUMAN ENDOTHELIAL-CELLS [J].

LEVIN, EG ;

MILES, LA ;

FLESS, GM ;

SCANU, AM ;

BAYNHAM, P ;

CURTISS, LK ;

PLOW, EF .

ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (03) :438-442

[77]

Lindsay R M, 1976, Clin Nephrol, V6, P335

[78]

LINDSAY RM, 1978, CLIN NEPHROL, V10, P67

[79] THE PROGNOSTIC VALUE OF C-REACTIVE PROTEIN AND SERUM AMYLOID-A PROTEIN IN SEVERE UNSTABLE ANGINA [J].

LIUZZO, G ;

BIASUCCI, LM ;

GALLIMORE, JR ;

GRILLO, RL ;

REBUZZI, AG ;

PEPYS, MB ;

MASERI, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (07) :417-424

[80]

LIVIO M, 1986, LANCET, V1, P414

← 3 4 5 6 7 8 9 10 11 12 →